News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
BERGER FRANKLIN M
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/11/2023 |
4
| BERGER FRANKLIN M (Director) has filed a Form 4 on Rain Oncology Inc.|
Txns:
| Granted 35,000 options to buy
@ $1.21, valued at
$42.4k
|
|
| 07/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2023 |
4
| BERGER FRANKLIN M (Director) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Granted 35,000 options to buy
@ $2.64, valued at
$92.4k
|
|
| 06/15/2023 |
4
| BERGER FRANKLIN M (Director) has filed a Form 4 on Atreca, Inc.|
Txns:
| Granted 12,000 options to buy
@ $1.18, valued at
$14.2k
|
|
| 01/05/2023 |
4
| BERGER FRANKLIN M (Director) has filed a Form 4 on ESSA Pharma Inc.|
Txns:
| Sold 25,000 shares
@ $3, valued at
$75k
Sold 32,000 shares
@ $2.9, valued at
$92.8k
Sold 50,000 shares
@ $2.86, valued at
$143k
Sold 50,000 shares
@ $2.67, valued at
$133.5k
Sold 43,617 shares
@ $2.53, valued at
$110.4k
Sold 37,889 shares
@ $2.41, valued at
$91.3k
Sold 34,334 shares
@ $2.42, valued at
$83.1k
|
|
| 11/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/15/2022 |
4
| BERGER FRANKLIN M (Director) has filed a Form 4 on Atea Pharmaceuticals, Inc.|
Txns:
| Sold 25,500 shares
@ $5.1503, valued at
$131.3k
Sold 16,166 shares
@ $5.156, valued at
$83.4k
|
|
| 11/14/2022 |
4
| BERGER FRANKLIN M (Director) has filed a Form 4 on Rain Therapeutics Inc.|
Txns:
| Bought 42,881 shares
@ $5.83, valued at
$250k
|
|
| 11/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/19/2022 |
4
| BERGER FRANKLIN M (Director) has filed a Form 4 on Rain Therapeutics Inc.|
Txns:
| Granted 20,000 options to buy
@ $2.44, valued at
$48.8k
|
|
| 06/21/2022 |
4
| BERGER FRANKLIN M (Director) has filed a Form 4 on Atea Pharmaceuticals, Inc.|
Txns:
| Granted 61,264 options to buy
@ $6.5, valued at
$398.2k
|
|
| 06/17/2022 |
4
| BERGER FRANKLIN M (Director) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Granted 26,000 options to buy
@ $4.8, valued at
$124.8k
|
|
| 06/10/2022 |
4
| BERGER FRANKLIN M (Director) has filed a Form 4 on Atreca, Inc.|
Txns:
| Granted 12,000 options to buy
@ $2.09, valued at
$25.1k
|
|
| 03/22/2022 |
4
| BERGER FRANKLIN M (Director) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Bought 15,000 shares
@ $15.96, valued at
$239.4k
Bought 45,000 shares
@ $17, valued at
$765k
Bought 20,000 shares
@ $14.77, valued at
$295.4k
|
|
| 09/23/2021 |
4
| BERGER FRANKLIN M (Director) has filed a Form 4 on Rain Therapeutics Inc.|
Txns:
| Bought 3,786 shares
@ $14.3, valued at
$54.1k
|
|
| 09/23/2021 |
4
| BERGER FRANKLIN M (Director) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Exercised 8,896 options to buy
@ $5.91, valued at
$52.6k
Exercised 8,896 options to buy
@ $7.63, valued at
$67.9k
Exercised 8,896 options to buy
@ $5.6, valued at
$49.8k
|
|
| 06/30/2021 |
4
| BERGER FRANKLIN M (Director) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Granted 26,000 options to buy
@ $5.59, valued at
$145.3k
|
|
| 06/21/2021 |
4
| BERGER FRANKLIN M (Director) has filed a Form 4 on Atea Pharmaceuticals, Inc.|
Txns:
| Granted 34,025 options to buy
@ $23.39, valued at
$795.8k
|
|
| 06/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2021 |
4
| BERGER FRANKLIN M (Director) has filed a Form 4 on Rain Therapeutics Inc.|
Txns:
| Granted 24,000 options to buy
@ $15.33, valued at
$367.9k
|
|
| 04/27/2021 |
4
| BERGER FRANKLIN M (Director) has filed a Form 4 on Rain Therapeutics Inc.|
Txns:
| Bought 120,000 shares
@ $17, valued at
$2M
Bought 5,000 shares
@ $15.78, valued at
$78.9k
Converted 175,939 shares
@ $0
Converted 535,601 shares
@ $0
Converted 189,998 preferred shares
@ $0
Converted 578,397 preferred shares
@ $0 |
|
| 04/22/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/19/2021 |
4
| BERGER FRANKLIN M (Director) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Disposed/sold 5,000 shares
@ $38, valued at
$190k
Disposed/sold 12,500 options to buy
@ $22.15, valued at
$276.9k
Disposed/sold 10,000 options to buy
@ $29.8, valued at
$298k
Disposed/sold 10,000 options to buy
@ $17.27, valued at
$172.7k
Disposed/sold 15,000 options to buy
@ $6.09, valued at
$91.4k
Disposed/sold 20,000 options to buy
@ $4.14, valued at
$82.8k
|
|
| 03/04/2021 |
4
| BERGER FRANKLIN M (Director) has filed a Form 4 on ESSA Pharma Inc.|
Txns:
| Bought 57,000 shares
@ $27, valued at
$1.5M
|
|
| 01/26/2021 |
4/A
| BERGER FRANKLIN M (Director) has filed a Form 4 on ESSA Pharma Inc.|
Txns:
| Granted 16,500 options to buy
@ $7, valued at
$115.5k
|
|
| 01/11/2021 |
4
| BERGER FRANKLIN M (Director) has filed a Form 4 on ESSA Pharma Inc.|
Txns:
| Exercised 1,716 options to buy
@ $4, valued at
$6.9k
Exercised 6,534 options to buy
@ $4, valued at
$26.1k
Exercised 2,184 options to buy
@ $3.81, valued at
$8.3k
Exercised 25,000 options to buy
@ $3.23, valued at
$80.8k
Exercised 6,773 options to buy
@ $4.67, valued at
$31.6k
Granted 16,500 options to buy
@ $7, valued at
$115.5k
|
|
| 11/03/2020 |
4
| BERGER FRANKLIN M (Director) has filed a Form 4 on Atea Pharmaceuticals, Inc.|
Txns:
| Converted 759,606 shares
@ $0
Bought 41,666 shares
@ $24, valued at
$1000k
Converted 400,000 convertible preferred
@ $0
Converted 132,014 convertible preferred
@ $0
Converted 131,578 convertible preferred
@ $0
Converted 60,540 convertible preferred
@ $0
Converted 35,474 convertible preferred
@ $0 |
|
| 10/30/2020 |
4
| BERGER FRANKLIN M (Director) has filed a Form 4 on Atea Pharmaceuticals, Inc.|
Txns:
| Granted 80,000 options to buy
@ $24, valued at
$1.9M
|
|
| 10/29/2020 |
3
| BERGER FRANKLIN M (Director) has filed a Form 3 on Atea Pharmaceuticals, Inc. |
| 10/01/2020 |
3
| BERGER FRANKLIN M (Director) has filed a Form 3 on ESSA Pharma Inc. |
| 07/01/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/26/2020 |
4
| BERGER FRANKLIN M (Director) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Granted 8,896 options to buy
@ $5.6, valued at
$49.8k
|
|
| 06/15/2020 |
4
| BERGER FRANKLIN M (Director) has filed a Form 4 on Atreca, Inc.|
Txns:
| Granted 12,000 options to buy
@ $17.87, valued at
$214.4k
|
|
| 06/11/2020 |
4
| BERGER FRANKLIN M (Director) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Bought 100,000 shares
@ $5.5, valued at
$550k
|
|
|
|
|